A NOVEL VACCINE FORMULATION CONSISTING OF DNA VACCA NOVEL VACCINE FORMULATION CONSISTING OF DNA VACCINE INACTIVATED VIRUS INE INACTIVATED VIRUS

A NOVEL VACCINE FORMULATION CONSISTING OF DNA VACCA NOVEL VACCINE FORMULATION CONSISTING OF DNA VACCINE INACTIVATED VIRUS INE INACTIVATED VIRUS

Disclosed herein is a novel vaccine formulation for prophylatic or therapeut ic immunization of vertebrates against infections caused by vertebrate viruses. The said vaccine contains a minimum of two components, one of which is a deoxyribonucleotide (DNA) vaccine comprising of a DNA molecule that en...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VILLUPPANOOR, ALWAR SRINIVASAN, GUDDETI, SREENIVASA REDDY, PUNDI, NARASIMHAN RANGARAJAN, SUBHABRATA, BISWAS
Format: Patent
Sprache:eng ; fre
Schlagworte:
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosed herein is a novel vaccine formulation for prophylatic or therapeut ic immunization of vertebrates against infections caused by vertebrate viruses. The said vaccine contains a minimum of two components, one of which is a deoxyribonucleotide (DNA) vaccine comprising of a DNA molecule that encodes a polypeptide of the virus and the other component consisting of inactivated form of the virus. This invention can also be used to develop low cost inactivated virus-based vaccines that contain much lower amount of the said virus than that present in similar vaccines known in the prior art. This invention also relates to a process of producing the said novel vaccine formulation and the use of the said formulation.